Skip to content

Investigation for the effects of hydrogen rich water on chronic hepatitis and liver cirrhosis

Investigation for the effects of hydrogen rich water on chronic hepatitis and liver cirrhosis - Hydrogen rich water for chronic hepatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010693
Enrollment
20
Registered
2013-05-20
Start date
2013-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis and liver cirrhosis

Interventions

GroupA:drink hydrogen rich water 1L/day for 1month, following 1month washout and drink control water 1L/day for 1month. GroupB:drink control water 1L/day for 1month, following 1 month washout and dri

Sponsors

Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.Department of Gastroenterology and Hepatology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)chronic hepatitis or liver cirrhosis diagnosed with liver biopsy or radiography and show ALT elevation with standard therapy. 2)Patients whose ALT levels kept beyond upper limit of normal range for more than 2 months.

Exclusion criteria

Exclusion criteria: 1)Patients who need albumin administration more than once /week for 1 month or more. 2)Patients with edema or ascite. 3)Patients with hepatic encephalopathy. 4)Bilirubin levels equal or >2mg/dl. 5)Albumin levels <3g/dl. 6)Serum Na <130 mEq/L 7)Alcohol abuser. 8)Creatinin equal or >1.3mg/dl. 9)Patients who are receiving interferon treatment. 10)Family Doctors comment

Design outcomes

Primary

MeasureTime frame
Reduction of high ALT

Countries

Japan

Contacts

Public ContactAkinobu Takaki

Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences. Department of Gastroenterology and Hepatology

akitaka@md.okayama-u.ac.jp086-235-7219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026